Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings

NCT04940039 is registered in ClinicalTrials.gov with Janssen-Cilag International NV as lead sponsor.

NCT NCT04940039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04940039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings
Lead sponsor
Janssen-Cilag International NV
Phase
Phase 4
Overall status
Completed
Start date
July 22, 2021
Completion date
April 16, 2024
Enrollment
93 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia